Investigation Report on China Fat Emulsion Market, 2010-2019

As an emulsion of soy bean oil, egg phospholipids and glycerin, fat emulsion injection provides essential fatty acids ...
Reference: 1509316
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
9/7/2015
Pages
40
Version:
2010
Charts:
35
Language
  • English
  • Chinese
Format
License

Description

As an emulsion of soy bean oil, egg phospholipids and glycerin, fat emulsion injection provides essential fatty acids for people who are unable to get nutrition via an oral diet.
The concept of fat emulsion dated back to the 1960s when hospitals in advanced countries found soy bean oil with its oleic acid and linoleic acid to be an ideal component of intravenous nutrition for critically ill patients like those who suffer from serious burn or advanced tumor and dyscrasia or those who had car accident or major surgery. Ever since 1961 when Interlipid, a soybean oil fat emulsion injection, was developed by scientists with Fresenius Kabi (Sweden) Co., Ltd, it has remained the best-selling injection. In 1983, Sino-Swed Pharmaceutical Corp. Ltd introduced raw material and patented technology from Fresenius Kabi (Sweden) Co., Ltd to produce Interlipid. In the mid-1980s, such western giants as Fresenius Company developed medium- and long-chain fatty acid injection with fewer adverse effects which was included by the National Health and Family Planning Commission of the People's Republic of China into the national medicare drug list as early as a decade ago.
The wide application of fat emulsion has been limited by its high unit price of CNY 80 despite an annual sales volume of over 10 million in recent years. But with rising ability to pay and increasing incidence of such diseases as malignant cancer, cardiovascular diseases and respiratory diseases caused by environmental pollution and lifestyle changes, the demand for fat emulsion will keep going up.
According to CRI's market survey, the sales value of fat emulsion in sample hospitals rose from less than CNY 300 million in 2005 to over CNY 900 million in 2014 and CAGR during this period surpassed 14%.
As Chinese people's capability to pay rises, fat emulsion, a component of intravenous nutrition, with its wide application in clinical practice, has witnessed a growing market and therefore good market prospects.

Readers can get at least the following information through this report:
-market size of fat emulsion in China
-competitive landscape of fat emulsion market in China
-price of fat emulsion made by different enterprises in China
-market outlook of fat emulsion in China

The author suggests the following groups of people purchase this report:
- Pharmaceutical Manufacturers
-investors/research institutions interested in Chinese medicine market
-any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1 Related Concepts of Fat Emulsion
1.1 Indication
1.2 Overview of Global Market

2 Market Profile of Fat Emulsion in China
2.1 Patent and Approval Information of Fat Emulsion in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Fat Emulsion Sales in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Fat Emulsion Manufacturers in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Fat Emulsion in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Fat Emulsion in Chinese Hospitals in 2014
6.1 Baxter Healthcare (Guangzhou) Co., Ltd
6.2 Sino-Swed Pharmaceutical Corp. Ltd
6.3 Chongqing Pharscin Pharmaceutical Co., Ltd
6.4 Fresenius Kabi (Sweden) Co., Ltd
6.5 Fresenius Kabi (Austria) Co., Ltd

7 Major Manufacturers of Fat Emulsion in Chinese Market, 2010-2014
7.1 Baxter Healthcare (Guangzhou) Co., Ltd
7.2 Sino-Swed Pharmaceutical Corp. Ltd
7.3 Fresenius Kabi (Sweden) Co., Ltd
7.4 B.Braun AG (Germany)

8 Market Outlook of Fat Emulsion in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Table of Selected Charts

Chart Patent Information of Fat Emulsion in China
Chart Some Approval Information of Fat Emulsion in China
Chart Fat Emulsion Sales in China
Chart Sales Value of Fat Emulsion in China, 2010-2014
Chart Sales Value of Fat Emulsion in Some Regions in China, 2010-2014
Chart Sales Volume of Fat Emulsion in China, 2010-2014
Chart Sales Volume of Fat Emulsion in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Fat Emulsion Manufacturers for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Fat Emulsion Made by Sino-Swed in China, 2010-2014
Chart Sales Value and Market Share of Fat Emulsion Made by Fresenius Kabi (Sweden) in China, 2010-2014
Chart Sales Value and Market Share of Fat Emulsion Made by Baxter Healthcare (Guangzhou) in China, 2010-2014
Chart Sales Value and Market Share of Fat Emulsion Made by B.Braun (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Fat Emulsion Made by Fresenius Kabi (AT) in China, 2010-2014
Chart Sales Value and Market Share of Fat Emulsion Injection in China, 2010-2014
Chart Sales Volume and Market Share of Fat Emulsion Tablet in China, 2010-2014
Chart Price of Fat Emulsion Made by Baxter Healthcare (Guangzhou) in Some Chinese Cities in 2014
Chart Price of Fat Emulsion Made by Sino-Swed in Some Chinese Cities in 2014
Chart Price of Fat Emulsion Made by B.Braun (Germany) in Some Chinese Cities in 2014
Chart Price of Fat Emulsion Made by Fresenius Kabi (Sweden) in Some Chinese Cities in 2014
Chart Price of Fat Emulsion Made by Fresenius Kabi (AT) in Some Chinese Cities in 2014
Scroll